ABL1 and leukemia: In addition, 7 out of 10 experimentally validated fusions had more than one chimeric RNAseq read, except for the well-known BCR-ABL1 fusion detected in one of the leukemia samples and two variants of SLC34A2-ROS1 detected in one of the lung cancer samples, which had only one chimeric read.